AbbVie Balance Sheet Health
Financial Health criteria checks 3/6
AbbVie has a total shareholder equity of $6.8B and total debt of $70.9B, which brings its debt-to-equity ratio to 1040%. Its total assets and total liabilities are $141.9B and $135.1B respectively. AbbVie's EBIT is $18.7B making its interest coverage ratio 9.8. It has cash and short-term investments of $13.2B.
Key information
1,040.0%
Debt to equity ratio
US$70.94b
Debt
| Interest coverage ratio | 9.8x |
| Cash | US$13.16b |
| Equity | US$6.82b |
| Total liabilities | US$135.12b |
| Total assets | US$141.94b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABBV's short term assets ($33.8B) do not cover its short term liabilities ($41.9B).
Long Term Liabilities: ABBV's short term assets ($33.8B) do not cover its long term liabilities ($93.2B).
Debt to Equity History and Analysis
Debt Level: ABBV's net debt to equity ratio (847.1%) is considered high.
Reducing Debt: ABBV had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: ABBV's debt is well covered by operating cash flow (26.3%).
Interest Coverage: ABBV's interest payments on its debt are well covered by EBIT (9.8x coverage).